Home > Riviste > Minerva Gastroenterologica e Dietologica > Fascicoli precedenti > Minerva Gastroenterologica e Dietologica 2017 September;63(3) > Minerva Gastroenterologica e Dietologica 2017 September;63(3):221-34

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

Rivista di Gastroenterologia, Nutrizione e Dietetica


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEW  GERD: THE NEVERENDING STORY


Minerva Gastroenterologica e Dietologica 2017 September;63(3):221-34

DOI: 10.23736/S1121-421X.17.02393-5

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Extra-esophageal presentation of gastroesophageal reflux disease: new understanding in a new era

Irene MARTINUCCI 1 , Eleonora ALBANO 1, Santino MARCHI 1, Corrado BLANDIZZI 2

1 Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; 2 Division of Pharmacology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy


PDF  


Associations of gastroesophageal reflux disease (GERD) with extraesophageal manifestations, such as chronic cough, asthma, and laryngitis, are reported frequently, and there is a strong evidence of biological plausibility in support of this relationship. On the other hand, extraesophageal reflux disease (EERD) is usually multifactorial in nature with reflux being just one of the several potential contributing cofactors. Moreover, the accuracy of currently available diagnostic tests for EERD is suboptimal, and therefore the causal relationship between GERD and EERD remains far from being conclusively proven. In addition, there is a general paucity of data supporting a beneficial effect of anti-reflux treatments on symptoms of patients with suspected EERD. Therefore, diagnostic as well as therapeutic management of EERD remains largely empirical. Current guidelines suggest an initial empiric trial of proton pump inhibitors in patients without alarm features, who present also typical GERD symptoms. For those patients who improve with PPIs, GERD is presumed to be the etiology. In patients with refractory reflux, combined impedance/pH monitoring might provide the single best strategy for evaluating reflux symptoms. In this context, as symptoms ascribable to GERD may depend on other causes, investigations that excludes GERD can help to redirect the diagnostic and treatment efforts to other pathological conditions. The present review intends to discuss the current state of knowledge regarding the challenging diagnostic and therapeutic management of patients with suspected EERD, emphasizing the points of strengths and limitations of currently available diagnostic options, and to provide an update on major diagnostic innovations in this area.


KEY WORDS: Gastroesophageal reflux - Laryngopharyngeal reflux - Asthma

inizio pagina

Publication History

Issue published online: June 19, 2017
Article first published online: March 3, 2017

Per citare questo articolo

Martinucci I, Albano E, Marchi S, Blandizzi C. Extra-esophageal presentation of gastroesophageal reflux disease: new understanding in a new era. Minerva Gastroenterol Dietol 2017;63:221-34. DOI: 10.23736/S1121-421X.17.02393-5

Corresponding author e-mail

martinucci.irene@gmail.com